| 1 |
Mallafré-larrosa M, Herrero Garcia M, Mendoza-funes S, Martínez-solanas È, Patsi-bosch G, Mendioroz Peña J, Ciruela Navas P. SARS-CoV-2 Contacts’ Symptom Development and Secondary Attack Rate: A Retrospective Analysis of a Contact-Tracing Cohort in Catalonia. COVID 2023;3:428-439. [DOI: 10.3390/covid3040032] [Reference Citation Analysis]
|
| 2 |
Strathdee SA, Abramovitz D, Vera CF, Artamonova I, Patterson TL, Smith DM, Chaillon A, Bazzi AR. Predictors of COVID-19 vaccine uptake among people who inject drugs. Vaccine 2023;41:1916-24. [PMID: 36697311 DOI: 10.1016/j.vaccine.2023.01.042] [Reference Citation Analysis]
|
| 3 |
Arash Letafati, Nooshin Eyvazzadeh, Amirhossein Gharehkhani, Ayeh Khorshidian, Siavash Chalabiani, Elnaz Khodadoust Soufiani, Niloofar Khakpoor, Benyamin Shamsodini, Taranom Beheshti, Raha Taheri Bavili Olyaei, Anahita Soleimani, Fatemeh Melyani, Ghazal Mashhadi Hossein. Comparison of AstraZeneca and sinopharm vaccines as boosters in protection against COVID-19 infection. Biologicals 2023:101668. [ DOI: 10.1016/j.biologicals.2023.101668] [Reference Citation Analysis]
|
| 4 |
Kissler SM, Hay JA, Fauver JR, Mack C, Tai CG, Anderson DJ, Ho DD, Grubaugh ND, Grad YH. Viral kinetics of sequential SARS-CoV-2 infections.. [DOI: 10.1101/2023.03.03.23286775] [Reference Citation Analysis]
|
| 5 |
Viloria Winnett A, Akana R, Shelby N, Davich H, Caldera S, Yamada T, Reyna JRB, Romano AE, Carter AM, Kim MK, Thomson M, Tognazzini C, Feaster M, Goh YY, Chew YC, Ismagilov RF. Extreme differences in SARS-CoV-2 viral loads among respiratory specimen types during presumed pre-infectious and infectious periods. PNAS Nexus 2023;2:pgad033. [PMID: 36926220 DOI: 10.1093/pnasnexus/pgad033] [Reference Citation Analysis]
|
| 6 |
Port JR, Morris DH, Riopelle JC, Yinda CK, Avanzato VA, Holbrook MG, Bushmaker T, Schulz JE, Saturday TA, Barbian K, Russel CA, Perry-Gottschalk R, Shaia CI, Martens C, Lloyd-Smith JO, Fischer RJ, Munster VJ. Host and viral determinants of airborne transmission of SARS-CoV-2 in the Syrian hamster. bioRxiv 2023:2022. [PMID: 36032963 DOI: 10.1101/2022.08.15.504010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Li Y, Harrison LJ, Chew KW, Currier JS, Wohl DA, Daar ES, Evering TH, Wu R, Giganti M, Ritz J, Javan AC, Coombs RW, Moser C, Hughes MD, Eron JJ, Smith DM, Li JZ. Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019. Clin Infect Dis 2023;76:734-7. [PMID: 36210483 DOI: 10.1093/cid/ciac818] [Reference Citation Analysis]
|
| 8 |
Hao L, Hsiang TY, Dalmat RR, Ireton R, Morton JF, Stokes C, Netland J, Hale M, Thouvenel C, Wald A, Franko NM, Huden K, Chu HY, Sigal A, Greninger AL, Tilles S, Barrett LK, Van Voorhis WC, Munt J, Scobey T, Baric RS, Rawlings DJ, Pepper M, Drain PK, Gale M Jr. Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron. Viruses 2023;15. [PMID: 36851745 DOI: 10.3390/v15020530] [Reference Citation Analysis]
|
| 9 |
Wong CKH, Lau KTK, Au ICH, Lau EHY, Poon LLM, Hung IFN, Cowling BJ, Leung GM. Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study. Lancet Infect Dis 2023:S1473-3099(22)00873-8. [PMID: 36796397 DOI: 10.1016/S1473-3099(22)00873-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 10 |
Gui H, Zhang Z, Chen B, Chen Y, Wang Y, Long Z, Zhu C, Wang Y, Cao Z, Xie Q. Development and validation of a nomogram to predict failure of 14-day negative nucleic acid conversion in adults with non-severe COVID-19 during the Omicron surge: a retrospective multicenter study. Infect Dis Poverty 2023;12:7. [PMID: 36750862 DOI: 10.1186/s40249-023-01057-4] [Reference Citation Analysis]
|
| 11 |
Cava F, San Román J, Barreiro P, Candel FJ, Álvarez-Timón FJ, Melero D, Coya N, Guillén R, Cantarero-Prieto D, Lera-Torres J, Cobo-Ortiz N, Canora J, Martínez-Peromingo FJ, Barba R, Carretero MDM, Losa JE, Zapatero A. Temporal Series Analysis of Population Cycle Threshold Counts as a Predictor of Surge in Cases and Hospitalizations during the SARS-CoV-2 Pandemic. Viruses 2023;15. [PMID: 36851635 DOI: 10.3390/v15020421] [Reference Citation Analysis]
|
| 12 |
Tan ST, Kwan AT, Rodríguez-Barraquer I, Singer BJ, Park HJ, Lewnard JA, Sears D, Lo NC. Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave. Nat Med 2023;29:358-65. [PMID: 36593393 DOI: 10.1038/s41591-022-02138-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 13 |
Contreras S, Oróstica KY, Daza-sanchez A, Wagner J, Dönges P, Medina-ortiz D, Jara M, Verdugo R, Conca C, Priesemann V, Olivera-nappa Á. Model-based assessment of sampling protocols for infectious disease genomic surveillance. Chaos, Solitons & Fractals 2023;167:113093. [DOI: 10.1016/j.chaos.2022.113093] [Reference Citation Analysis]
|
| 14 |
Ghafari M, Hall M, Golubchik T, Ayoubkhani D, House T, Macintyre-cockett G, Fryer H, Thomson L, Nurtay A, Buck D, Green A, Trebes A, Piazza P, Lonie LJ, Studley R, Rourke E, Smith D, Bashton M, Nelson A, Crown M, Mccann C, Young GR, dos Santos RAN, Richards Z, Tariq A, Cahuantzi R, Barrett J, Fraser C, Bonsall D, Walker AS, Lythgoe K, Wellcome Sanger Institute COVID-19 Surveillance Team, COVID-19 Infection Survey Group, The COVID-19 Genomics UK (COG-UK) Consortium. High number of SARS-CoV-2 persistent infections uncovered through genetic analysis of samples from a large community-based surveillance study.. [DOI: 10.1101/2023.01.29.23285160] [Reference Citation Analysis]
|
| 15 |
Jacobs JL, Haidar G, Mellors JW. COVID-19: Challenges of Viral Variants. Annu Rev Med 2023;74:31-53. [PMID: 35850493 DOI: 10.1146/annurev-med-042921-020956] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 16 |
Fernandez-Montero A, Zuaznabar J, Pina-Sanchez M, Maestro S, Martin-Navarro L, Muñoz-Rodríguez N, Olagüe C, Pastrana M, Martínez-Fernández M, Camps G, Rodriguez JA, Marchese FP, Zazpe J, Pozuelo M, Del Pozo JL, Quiroga J, Pineda-Lucena A, Reina G, Kolenda J, Moreno-Galarraga L, Gonzalez-Aseguinolaza G, Rua M, Smerdou C, Carmona-Torre F, Argemi J. Photodynamic nasal SARS-CoV-2 decolonization shortens infectivity and influences specific T-Cell responses. Front Cell Infect Microbiol 2023;13:1110467. [PMID: 36761900 DOI: 10.3389/fcimb.2023.1110467] [Reference Citation Analysis]
|
| 17 |
Bugallo-Sanz X, Balboa-Barreiro V, Pérez-Martínez O, García-Rodríguez R, Gómez-Besteiro I, Pereira-Rodríguez MJ. [COVID-19 epidemiology in health and social health workers in the health area of A Coruña and Cee]. Semergen 2023;49:101938. [PMID: 36889056 DOI: 10.1016/j.semerg.2023.101938] [Reference Citation Analysis]
|
| 18 |
Mueller S. Other Facets of SARS-CoV-2 Immunity, the Risk of Immune Tolerance and T Cell Exhaustion. Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2 2023. [DOI: 10.1007/978-3-031-18903-6_11] [Reference Citation Analysis]
|
| 19 |
Scales SE, Horney JA. Implementing public health control measures. The COVID-19 Response 2023. [DOI: 10.1016/b978-0-323-98810-0.00009-0] [Reference Citation Analysis]
|
| 20 |
Mueller S. Omicron. Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2 2023. [DOI: 10.1007/978-3-031-18903-6_12] [Reference Citation Analysis]
|
| 21 |
Tiwari A, Sharan TS, Sharma S, Sharma N, Jin Z. Deep learning-based automated multiclass classification of chest X-rays into Covid-19, normal, bacterial pneumonia and viral pneumonia. Cogent Engineering 2022;9:2105559. [DOI: 10.1080/23311916.2022.2105559] [Reference Citation Analysis]
|
| 22 |
Viloria Winnett A, Porter MK, Romano AE, Savela ES, Akana R, Shelby N, Reyes JA, Schlenker NW, Cooper MM, Carter AM, Ji J, Barlow JT, Tognazzini C, Feaster M, Goh YY, Ismagilov RF. Morning SARS-CoV-2 Testing Yields Better Detection of Infection Due to Higher Viral Loads in Saliva and Nasal Swabs upon Waking. Microbiol Spectr 2022;10:e0387322. [PMID: 36287073 DOI: 10.1128/spectrum.03873-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Robalo Q, De Mot L, Vandromme M, Van Goethem N, Gabrio A, Chung PYJ, Meurisse M, Belgian Collaborative Group On Covid-Hospital Surveillance, Catteau L, Thijs C, Blot K. Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study. Vaccines (Basel) 2022;11. [PMID: 36679859 DOI: 10.3390/vaccines11010014] [Reference Citation Analysis]
|
| 24 |
Chen Hu, Yu-Kai Liu, Qi-Di Sun, Zheng Du, Yu-Qiang Fang, Fei Guo, Yu-Bo Wang, Yong He, Yuan Cen, Fan Zeng. Clinical characteristics and risk factors for a prolonged length of stay of patients with asymptomatic and mild COVID-19 during the wave of Omicron from Shanghai, China. BMC Infect Dis 2022;22:947. [PMID: 36526990 DOI: 10.1186/s12879-022-07935-w] [Reference Citation Analysis]
|
| 25 |
Buonsenso D, Perramon A, Català M, Torres JP, Camacho-Moreno G, Rojas-Solano M, Ulloa-Gutierrez R, Camacho-Badilla K, Pérez-Corrales C, Cotugno N, Yamazaki-Nakashimada MA, Estripeaut D, Buddingh EP, von Asmuth E, van Rossum AMC, Soler-Palacin P, Rivière JG, Prats C, Pino R, Paredes-Carmona F, Visa-Reñé N, García-Salido A, Martínez-Mejias A, Soriano-Arandes A; COPP-consortium, COPEDI-CAT Research Group. Multisystem Inflammatory Syndrome in Children in Western Countries? Decreasing Incidence as the Pandemic Progresses?: An Observational Multicenter International Cross-sectional Study. Pediatr Infect Dis J 2022;41:989-93. [PMID: 36102705 DOI: 10.1097/INF.0000000000003713] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 26 |
Kandel C, Lee Y, Taylor M, Llanes A, McCready J, Crowl G, Powis J, Li AX, Shigayeva A, Yip L, Katz K, Kozak R, Mubareka S, McGeer A. Viral dynamics of the SARS-CoV-2 Omicron Variant among household contacts with 2 or 3 COVID-19 vaccine doses. J Infect 2022;85:666-70. [PMID: 36283495 DOI: 10.1016/j.jinf.2022.10.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 27 |
Tan ST, Kwan AT, Rodríguez-Barraquer I, Singer BJ, Park HJ, Lewnard JA, Sears D, Lo NC. Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave. medRxiv 2022:2022. [PMID: 36299430 DOI: 10.1101/2022.08.08.22278547] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 28 |
Hay JA, Kissler SM, Fauver JR, Mack C, Tai CG, Samant RM, Connolly S, Anderson DJ, Khullar G, MacKay M, Patel M, Kelly S, Manhertz A, Eiter I, Salgado D, Baker T, Howard B, Dudley JT, Mason CE, Nair M, Huang Y, DiFiori J, Ho DD, Grubaugh ND, Grad YH. Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: A retrospective cohort study. Elife 2022;11. [PMID: 36383192 DOI: 10.7554/eLife.81849] [Cited by in Crossref: 10] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 29 |
Kissler S. Revealing contagion. Science 2022;378:611-611. [DOI: 10.1126/science.ade3133] [Reference Citation Analysis]
|
| 30 |
Thalheim T, Krüger T, Galle J. Indirect Virus Transmission via Fomites Can Counteract Lock-Down Effectiveness. Int J Environ Res Public Health 2022;19. [PMID: 36360891 DOI: 10.3390/ijerph192114011] [Reference Citation Analysis]
|
| 31 |
Jin A, Sharifi H. A SEIRD+V Model for the Effect of Vaccination and Social Distancing on SARS-CoV-2 Infection and Mortality.. [DOI: 10.1101/2022.10.23.22281416] [Reference Citation Analysis]
|
| 32 |
Gunawardana M, Webster S, Rivera S, Cortez JM Jr, Breslin J, Pinales C, Buser C, Ibarrondo FJ, Yang OO, Bobardt M, Gallay PA, Adler AP, Ramirez CM, Anton PA, Baum MM. Early SARS-CoV-2 dynamics and immune responses in unvaccinated participants of an intensely sampled longitudinal surveillance study. Commun Med (Lond) 2022;2:129. [PMID: 36238348 DOI: 10.1038/s43856-022-00195-4] [Reference Citation Analysis]
|
| 33 |
da Silva SJR. The emergence of new SARS-CoV-2 omicron subvariants introduces uncertainty about the end of the COVID-19 pandemic. Front Med (Lausanne) 2022;9:1010489. [PMID: 36300185 DOI: 10.3389/fmed.2022.1010489] [Reference Citation Analysis]
|
| 34 |
Van Egeren D, Stoddard M, White LF, Hochberg NS, Rogers MS, Zetter B, Joseph-mccarthy D, Chakravarty A. Vaccines alone cannot slow the evolution of SARS-CoV-2.. [DOI: 10.1101/2022.10.04.22280696] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 35 |
Schmitt CA, Tchkonia T, Niedernhofer LJ, Robbins PD, Kirkland JL, Lee S. COVID-19 and cellular senescence. Nat Rev Immunol 2022. [PMID: 36198912 DOI: 10.1038/s41577-022-00785-2] [Reference Citation Analysis]
|
| 36 |
Marquez C, Kerkhoff AD, Schrom J, Rojas S, Black D, Mitchell A, Wang CY, Pilarowski G, Ribeiro S, Jones D, Payan J, Manganelli S, Rojas S, Lemus J, Jain V, Chamie G, Tulier-Laiwa V, Petersen M, DeRisi J, Havlir DV. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods. JAMA Netw Open 2022;5:e2235844. [PMID: 36215069 DOI: 10.1001/jamanetworkopen.2022.35844] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 37 |
Raymenants J, Duthoo W, Stakenborg T, Verbruggen B, Verplanken J, Feys J, Van Duppen J, Hanifa R, Marchal E, Lambrechts A, Maes P, André E, Van den Wijngaert N, Peumans P. Exhaled breath SARS-CoV-2 shedding patterns across variants of concern. Int J Infect Dis 2022;123:25-33. [PMID: 35932968 DOI: 10.1016/j.ijid.2022.07.069] [Reference Citation Analysis]
|
| 38 |
Riemersma KK, Haddock LA, Wilson NA, Minor N, Eickhoff J, Grogan BE, Kita-yarbro A, Halfmann PJ, Segaloff HE, Kocharian A, Florek KR, Westergaard R, Bateman A, Jeppson GE, Kawaoka Y, O’connor DH, Friedrich TC, Grande KM. Shedding of infectious SARS-CoV-2 despite vaccination. PLoS Pathog 2022;18:e1010876. [DOI: 10.1371/journal.ppat.1010876] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 39 |
Muadchimkaew M, Siripongboonsitti T, Wongpatcharawarakul S, Boonsankaew C, Tawinprai K, Soonklang K, Mahanonda N. Effect of Inactivated SARS-CoV-2 Vaccines and ChAdOx1 nCoV-19 Vaccination to Prevent COVID-19 in Thai Households (VacPrevent trial). Int J Infect Dis 2022:S1201-9712(22)00531-8. [PMID: 36180032 DOI: 10.1016/j.ijid.2022.09.032] [Reference Citation Analysis]
|
| 40 |
Saade C, Brengel-Pesce K, Gaymard A, Trabaud MA, Destras G, Oriol G, Cheynet V, Debombourg M, Mokdad B, Billaud G, Oblette A, Créhalet H, Giannoli JM, Garrigou C, Generenaz L, Compagnon C, Boibieux A, Lina B, Morfin F, Pozzetto B, Josset L, Touillet-Assant S, Bal A, On Behalf Of Lyon Covid Study Group A. Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections. Emerg Microbes Infect 2022;:1-31. [PMID: 36098494 DOI: 10.1080/22221751.2022.2122578] [Reference Citation Analysis]
|
| 41 |
Krutova M, Brajerova M, Kepka Z, Briksi A, Hubacek P, Drevinek P. The evaluation of an automated mariPOC SARS-CoV-2 antigen test compared to RT-qPCR SARS-CoV-2 assay and comparison of its sensitivity in Delta- and Omicron-variant samples. Influenza Other Respir Viruses 2022. [PMID: 36065770 DOI: 10.1111/irv.13048] [Reference Citation Analysis]
|
| 42 |
DiIorio M, Kennedy K, Liew JW, Putman MS, Sirotich E, Sattui SE, Foster G, Harrison C, Larché MJ, Levine M, Moni TT, Thabane L, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Gore-Massy M, Howard RA, Kodhek MA, Lalonde N, Tomasella LA, Wallace J, Akpabio A, Alpízar-Rodríguez D, Beesley RP, Berenbaum F, Bulina I, Chock EY, Conway R, Duarte-García A, Duff E, Gheita TA, Graef ER, Hsieh E, El Kibbi L, Liew DF, Lo C, Nudel M, Singh AD, Singh JA, Singh N, Ugarte-Gil MF, Hausmann JS, Simard JF, Sparks JA. Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open 2022;8. [PMID: 36104117 DOI: 10.1136/rmdopen-2022-002587] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 43 |
Quiner C, Jones K, Bobashev G. Impacts of timing, length, and intensity of behavioral interventions to COVID-19 dynamics: North Carolina county-level examples. Infect Dis Model 2022;7:535-44. [PMID: 35992738 DOI: 10.1016/j.idm.2022.08.002] [Reference Citation Analysis]
|
| 44 |
Hao L, Hsiang TY, Dalmat RR, Ireton R, Morton J, Stokes C, Netland J, Hale M, Thouvenel C, Wald A, Franko NM, Huden K, Chu H, Greninger A, Tilles S, Barrett LK, Van Voorhis WC, Munt J, Scobey T, Baric RS, Rawlings D, Pepper M, Drain PK, Gale M. Dynamics of SARS-CoV-2 VOC neutralization and novel mAb reveal protection against Omicron. medRxiv 2022:2022. [PMID: 36032965 DOI: 10.1101/2022.08.12.22278720] [Reference Citation Analysis]
|
| 45 |
Zee ST, Kwok LF, Kee KM, Fung LH, Luk WP, Chan TL, Leung CP, Yu PW, Hung J, SzeTo KY, Chan WL, Tang SF, Lin WC, Ma SK, Lee KH, Lau CC, Yung WH. Impact of COVID-19 Vaccination on Healthcare Worker Infection Rate and Outcome during SARS-CoV-2 Omicron Variant Outbreak in Hong Kong. Vaccines (Basel) 2022;10. [PMID: 36016210 DOI: 10.3390/vaccines10081322] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 46 |
Iman Rezaee Azhar, Mahmood Yaghoobi, Leila Ghalich, Zahra Masoudian, Aida Shabanzadeh Pirsaraei, Peyman Yaghoobi, Mina Hamednaghsheh, Amir Mohammad Roshanaie Zadeh, Parsa Ghafari, Saba Soltani, Soraya Bozorgmehr, Motahareh Shafiei, Seyedeh Elham Mortazavi, Azam Ghaziasadi, Bahram Sharafkhanian, Hamid Akhiani, Jamshid Javidnejad, Bizhan Nomanpour, Farid Araeynejad, Seyed Mohammad Jazayeri. Socio-demographical Profile of 7285 SARS-Cov-2 Positive Early Cases; Comparison with National Four Epidemic Waves. Med J Islam Repub Iran 2022;36:131. [PMID: 36475093 DOI: 10.47176/mjiri.36.131] [Reference Citation Analysis]
|
| 47 |
Karron RA, Hetrich MK, Na YB, Knoll MD, Schappell E, Meece J, Hanson E, Tong S, Lee JS, Veguilla V, Dawood FS; SEARCH Study Team. Assessment of Clinical and Virological Characteristics of SARS-CoV-2 Infection Among Children Aged 0 to 4 Years and Their Household Members. JAMA Netw Open 2022;5:e2227348. [PMID: 36044218 DOI: 10.1001/jamanetworkopen.2022.27348] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 48 |
Hakki S, Zhou J, Jonnerby J, Singanayagam A, Barnett JL, Madon KJ, Koycheva A, Kelly C, Houston H, Nevin S, Fenn J, Kundu R, Crone MA, Pillay TD, Ahmad S, Derqui-fernandez N, Conibear E, Freemont PS, Taylor GP, Ferguson N, Zambon M, Barclay WS, Dunning J, Lalvani A, Badhan A, Varro R, Luca C, Quinn V, Cutajar J, Nichols N, Russell J, Grey H, Ketkar A, Miserocchi G, Tejpal C, Catchpole H, Nixon K, Di Biase B, Hopewell T, Narean JS, Samuel J, Timcang K, Mcdermott E, Bremang S, Hammett S, Evetts S, Kondratiuk A. Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study. The Lancet Respiratory Medicine 2022. [DOI: 10.1016/s2213-2600(22)00226-0] [Reference Citation Analysis]
|
| 49 |
Wells CR, Gokcebel S, Pandey A, Galvani AP, Townsend JP. Testing for COVID-19 is Much More Effective When Performed Immediately Prior to Social Mixing. Int J Public Health 2022;67:1604659. [DOI: 10.3389/ijph.2022.1604659] [Reference Citation Analysis]
|
| 50 |
Wells CR, Pandey A, Gokcebel S, Krieger G, Donoghue AM, Singer BH, Moghadas SM, Galvani AP, Townsend JP. Quarantine and serial testing for variants of SARS-CoV-2 with benefits of vaccination and boosting on consequent control of COVID-19. PNAS Nexus 2022;1:pgac100. [PMID: 35909795 DOI: 10.1093/pnasnexus/pgac100] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 51 |
Killian JT Jr, Houp JA, Burkholder GA, Roman Soto SA, Killian AC, Ong SC, Erdmann NB, Goepfert PA, Hauptfeld-Dolejsek V, Leal SM Jr, Zumaquero E, Nellore A, Agarwal G, Kew CE, Orandi BJ, Locke JE, Porrett PM, Levitan EB, Kumar V, Lund FE. COVID-19 Vaccination and Remdesivir are Associated With Protection From New or Increased Levels of Donor-Specific Antibodies Among Kidney Transplant Recipients Hospitalized With COVID-19. Transpl Int 2022;35:10626. [PMID: 35928347 DOI: 10.3389/ti.2022.10626] [Reference Citation Analysis]
|
| 52 |
Winnett AV, Akana R, Shelby N, Davich H, Caldera S, Yamada T, Reyna JRB, Romano AE, Carter AM, Kim MK, Thomson M, Tognazzini C, Feaster M, Goh Y, Chew YC, Ismagilov RF. SARS-CoV-2 exhibits extreme differences in early viral loads among specimen types suggesting improved detection of pre-infectious and infectious individuals using combination specimen types.. [DOI: 10.1101/2022.07.13.22277113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 53 |
da Silva ES, Kohnen M, Gilson G, Staub T, Arendt V, Hilger C, Servais J, Charpentier E, Domingues O, Snoeck CJ, Ollert M, Seguin-devaux C, Perez-bercoff D. Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone. IJMS 2022;23:7675. [DOI: 10.3390/ijms23147675] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 54 |
Mick E, Tsitsiklis A, Spottiswoode N, Caldera S, Serpa PH, Detweiler AM, Neff N, Pisco AO, Li LM, Retallack H, Ratnasiri K, Williamson KM, Soesanto V, Simões EAF, Smith C, Abuogi L, Kistler A, Wagner BD, DeRisi JL, Ambroggio L, Mourani PM, Langelier CR. Upper airway gene expression shows a more robust adaptive immune response to SARS-CoV-2 in children. Nat Commun 2022;13:3937. [PMID: 35803954 DOI: 10.1038/s41467-022-31600-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 55 |
Mullin S, Wyk BV, Asher JL, Compton SR, Allore HG, Zeiss CJ. Modeling pandemic to endemic patterns of SARS-CoV-2 transmission using parameters estimated from animal model data. PNAS Nexus 2022;1:pgac096. [PMID: 35799833 DOI: 10.1093/pnasnexus/pgac096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 56 |
Sarah Mullin, Brent Vander Wyk, Jennifer L Asher, Susan R Compton, Heather G Allore, Caroline J Zeiss. Modeling pandemic to endemic patterns of SARS-CoV-2 transmission using parameters estimated from animal model data. PNAS Nexus 2022;1:pgac096. [PMID: 35799833 DOI: 10.1093/pnasnexus/pgac096] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 57 |
Tunheim G, Rø GØI, Chopra A, Aase A, Kran AB, Vaage JT, Lund-Johansen F, Hungnes O. Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021. Influenza Other Respir Viruses 2022. [PMID: 35770841 DOI: 10.1111/irv.13024] [Reference Citation Analysis]
|
| 58 |
Batista-roche JL, Gómez-gil B, Lund G, Berlanga-robles CA, García-gasca A. Global m6A RNA Methylation in SARS-CoV-2 Positive Nasopharyngeal Samples in a Mexican Population: A First Approximation Study. Epigenomes 2022;6:16. [DOI: 10.3390/epigenomes6030016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 59 |
Barker KR, Small LN, Thai DV, Sohn KY, Rosella LC. Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay. Microbiol Spectr 2022;10:e0051322. [PMID: 35579469 DOI: 10.1128/spectrum.00513-22] [Reference Citation Analysis]
|
| 60 |
Santos da Silva E, Kohnen M, Gilson G, Staub T, Arendt V, Hilger C, Servais J, Charpentier E, Domingues O, Snoeck CJ, Ollert M, Seguin-devaux C, Perez-bercoff D. Pre-Omicron vaccine breakthrough infection induces superior cross-neutralization against SARS-CoV-2 Omicron BA.1 than primo infection.. [DOI: 10.1101/2022.06.21.22276659] [Reference Citation Analysis]
|
| 61 |
Watson JA, Kissler SM, Day NPJ, Grad YH, White NJ. Characterizing SARS-CoV-2 Viral Clearance Kinetics to Improve the Design of Antiviral Pharmacometric Studies. Antimicrob Agents Chemother 2022;:e0019222. [PMID: 35736134 DOI: 10.1128/aac.00192-22] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 62 |
Zipfel CM, Paul P, Gowler CD, Reddy SC, Stone ND, Jacobs Slifka K, Slayton RB. Modeling the Effectiveness of Healthcare Personnel Reactive Testing and Screening for the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Variant Within Nursing Homes. Clin Infect Dis 2022;75:S225-30. [PMID: 35724112 DOI: 10.1093/cid/ciac505] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 63 |
Funk S, Abbott S. Cycle threshold values in symptomatic COVID-19 cases in England.. [DOI: 10.1101/2022.06.13.22276321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 64 |
Achenbach CJ, Caputo M, Hawkins C, Balmert LC, Qi C, Odorisio J, Dembele E, Jackson A, Abbas H, Frediani JK, Levy JM, Rebolledo PA, Kempker RR, Esper AM, Lam WA, Martin GS, Murphy RL. Clinical evaluation of the Diagnostic Analyzer for Selective Hybridization (DASH): A point-of-care PCR test for rapid detection of SARS-CoV-2 infection. PLoS ONE 2022;17:e0270060. [DOI: 10.1371/journal.pone.0270060] [Reference Citation Analysis]
|
| 65 |
Kang SW, Kim JY, Park H, Lim SY, Kim J, Bae S, Jung J, Kim MJ, Chong YP, Lee SO, Choi SH, Kim YS, Park MS, Kim SH. Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection. J Infect 2022:S0163-4453(22)00355-3. [PMID: 35705135 DOI: 10.1016/j.jinf.2022.06.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 66 |
Hoteit R, Yassine HM. Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences. Vaccines (Basel) 2022;10:919. [PMID: 35746526 DOI: 10.3390/vaccines10060919] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 67 |
Walker J, Grubaugh ND, Gonsalves G, Pitzer V, Rizvi Z. One Million and Counting: Estimates of Deaths in the United States from Ancestral SARS-CoV-2 and Variants.. [DOI: 10.1101/2022.05.31.22275835] [Reference Citation Analysis]
|
| 68 |
Yang B, Lin Y, Cowling BJ. Accuracy for key parameters in modelling study. The Lancet Public Health 2022;7:e494. [DOI: 10.1016/s2468-2667(22)00085-8] [Reference Citation Analysis]
|
| 69 |
Mitsumura T, Okamoto T, Tosaka M, Yamana T, Shimada S, Iijima Y, Sakakibara R, Shibata S, Honda T, Shirai T, Ishizuka M, Aiboshi J, Furusawa H, Tateishi T, Tamaoka M, Shigemitsu H, Arai H, Otomo Y, Tohda S, Anzai T, Takahashi K, Yasuda S, Miyazaki Y. SARS-CoV-2 RNA copy number is a factor associated with the mortality of COVID-19 and improves the predictive performance of mortality in severe cases. Jpn J Infect Dis 2022. [PMID: 35650037 DOI: 10.7883/yoken.JJID.2022.080] [Reference Citation Analysis]
|
| 70 |
Marquez C, Kerkhoff AD, Schrom J, Rojas S, Black D, Mitchell A, Wang C, Pilarowski G, Ribeiro S, Jones D, Payan J, Manganelli S, Rojas S, Lemus J, Jain V, Chamie G, Tulier-laiwa V, Petersen M, Derisi J, Havlir DV. COVID-19 symptoms and duration of direct antigen test positivity at a community testing and surveillance site, January 2021-2022.. [DOI: 10.1101/2022.05.19.22274968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 71 |
Kandel CE, Banete A, Taylor M, Llanes A, Mccready J, Crowl G, Young M, Li AX, Chien E, Yim W, Yip L, Kozak R, Mcgeer AJ, Mubareka S, Powis JE. Similar duration of viral shedding of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta variant between vaccinated and incompletely vaccinated individuals. Infect Control Hosp Epidemiol 2022. [DOI: 10.1017/ice.2022.124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 72 |
Han WGH, Swart A, Bonačić Marinović A, Eggink D, Reimerink J, Wijsman LA, van der Veer B, van den Brink S, van den Brandt AM, van Tol S, Godeke GJ, Brouwer F, Hoogerwerf M, Reukers DFM, Rots N, Reusken C, Meijer A; Dutch F. F. X.-COVID-19 Research Group. SARS-CoV-2 RNA and antibody dynamics in a Dutch household study with dense sampling frame. Sci Rep 2022;12:7937. [PMID: 35562380 DOI: 10.1038/s41598-022-11480-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 73 |
Gowler CD, Paul P, Reddy SC. Viral Shedding Kinetics and Transmission of Emerging SARS-CoV-2 Variants-Critical Components of Study Design. JAMA Netw Open 2022;5:e2213614. [PMID: 35608863 DOI: 10.1001/jamanetworkopen.2022.13614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 74 |
Jung J, Kim JY, Park H, Park S, Lim JS, Lim SY, Bae S, Lim YJ, Kim EO, Kim J, Park MS, Kim SH. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals. JAMA Netw Open 2022;5:e2213606. [PMID: 35608859 DOI: 10.1001/jamanetworkopen.2022.13606] [Cited by in Crossref: 35] [Cited by in F6Publishing: 15] [Article Influence: 35.0] [Reference Citation Analysis]
|
| 75 |
Hart WS, Miller E, Andrews NJ, Waight P, Maini PK, Funk S, Thompson RN. Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis. The Lancet Infectious Diseases 2022;22:603-10. [DOI: 10.1016/s1473-3099(22)00001-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 51] [Article Influence: 37.0] [Reference Citation Analysis]
|
| 76 |
Bardosh K, de Figueiredo A, Gur-Arie R, Jamrozik E, Doidge J, Lemmens T, Keshavjee S, Graham JE, Baral S. The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good. BMJ Glob Health 2022;7:e008684. [PMID: 35618306 DOI: 10.1136/bmjgh-2022-008684] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 77 |
Connors JM, Iba T. Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer. Thromb Res 2022;213 Suppl 1:S77-83. [PMID: 36210565 DOI: 10.1016/j.thromres.2022.02.009] [Reference Citation Analysis]
|
| 78 |
Brümmer LE, Katzenschlager S, McGrath S, Schmitz S, Gaeddert M, Erdmann C, Bota M, Grilli M, Larmann J, Weigand MA, Pollock NR, Macé A, Erkosar B, Carmona S, Sacks JA, Ongarello S, Denkinger CM. Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors. PLoS Med 2022;19:e1004011. [PMID: 35617375 DOI: 10.1371/journal.pmed.1004011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 79 |
Takahashi K, Ishikane M, Ujiie M, Iwamoto N, Okumura N, Sato T, Nagashima M, Moriya A, Suzuki M, Hojo M, Kanno T, Saito S, Miyamoto S, Ainai A, Tobiume M, Arashiro T, Fujimoto T, Saito T, Yamato M, Suzuki T, Ohmagari N. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees. Emerg Infect Dis 2022;28:998-1001. [PMID: 35290176 DOI: 10.3201/eid2805.220197] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 80 |
Servellita V, Syed AM, Morris MK, Brazer N, Saldhi P, Garcia-Knight M, Sreekumar B, Khalid MM, Ciling A, Chen PY, Kumar GR, Gliwa AS, Nguyen J, Sotomayor-Gonzalez A, Zhang Y, Frias E, Prostko J, Hackett J Jr, Andino R, Wadford DA, Hanson C, Doudna J, Ott M, Chiu CY. Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants. Cell 2022;185:1539-1548.e5. [PMID: 35429436 DOI: 10.1016/j.cell.2022.03.019] [Cited by in Crossref: 42] [Cited by in F6Publishing: 19] [Article Influence: 42.0] [Reference Citation Analysis]
|
| 81 |
Bogaty P. Rapid Diagnostic Testing for SARS-CoV-2. N Engl J Med 2022;386:e47. [PMID: 35417629 DOI: 10.1056/NEJMc2202308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 82 |
Leekha A, Saeedi A, Kumar M, Sefat SR, Martinez-paniagua M, Fathi M, Kulkarni R, Biswas S, Tsitoura D, Liu X, Cooper LJ, Sebastian M, Hurst BL, Varadarajan N. An intranasal nanoparticle STING agonist has broad protective immunity against respiratory viruses and variants.. [DOI: 10.1101/2022.04.18.488695] [Reference Citation Analysis]
|
| 83 |
Earnest R, Uddin R, Matluk N, Renzette N, Turbett SE, Siddle KJ, Loreth C, Adams G, Tomkins-Tinch CH, Petrone ME, Rothman JE, Breban MI, Koch RT, Billig K, Fauver JR, Vogels CBF, Bilguvar K, De Kumar B, Landry ML, Peaper DR, Kelly K, Omerza G, Grieser H, Meak S, Martha J, Dewey HB, Kales S, Berenzy D, Carpenter-Azevedo K, King E, Huard RC, Novitsky V, Howison M, Darpolor J, Manne A, Kantor R, Smole SC, Brown CM, Fink T, Lang AS, Gallagher GR, Pitzer VE, Sabeti PC, Gabriel S, MacInnis BL, Tewhey R, Adams MD, Park DJ, Lemieux JE, Grubaugh ND; New England Variant Investigation Team. Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA. Cell Rep Med 2022;3:100583. [PMID: 35480627 DOI: 10.1016/j.xcrm.2022.100583] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 84 |
Pung R, Firth JA, Spurgin LG, Lee VJ, Kucharski AJ; Singapore CruiseSafe working group, CMMID COVID-19 working group. Using high-resolution contact networks to evaluate SARS-CoV-2 transmission and control in large-scale multi-day events. Nat Commun 2022;13:1956. [PMID: 35414056 DOI: 10.1038/s41467-022-29522-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 85 |
Oh C, Sashittal P, Zhou A, Wang L, El-Kebir M, Nguyen TH. Design of SARS-CoV-2 Variant-Specific PCR Assays Considering Regional and Temporal Characteristics. Appl Environ Microbiol 2022;88:e0228921. [PMID: 35285246 DOI: 10.1128/aem.02289-21] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 86 |
Knyazev S, Chhugani K, Sarwal V, Ayyala R, Singh H, Karthikeyan S, Deshpande D, Baykal PI, Comarova Z, Lu A, Porozov Y, Vasylyeva TI, Wertheim JO, Tierney BT, Chiu CY, Sun R, Wu A, Abedalthagafi MS, Pak VM, Nagaraj SH, Smith AL, Skums P, Pasaniuc B, Komissarov A, Mason CE, Bortz E, Lemey P, Kondrashov F, Beerenwinkel N, Lam TT, Wu NC, Zelikovsky A, Knight R, Crandall KA, Mangul S. Unlocking capacities of genomics for the COVID-19 response and future pandemics. Nat Methods 2022. [PMID: 35396471 DOI: 10.1038/s41592-022-01444-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 87 |
Baek YJ, Lee YJ, Kim JI, Lee S, Kim J, Lee EH, Lee KH, Kim JH, Ahn JY, Jeong SJ, Ku NS, Yeom JS, Choi JY. Prolonged viral shedding in severely ill patients infected with SARS-CoV-2 Delta variants: a retrospective cohort study. J Infect 2022:S0163-4453(22)00186-4. [PMID: 35395316 DOI: 10.1016/j.jinf.2022.04.003] [Reference Citation Analysis]
|
| 88 |
Phillips MC, Quintero D, Wald-dickler N, Holtom P, Butler-wu SM. SARS-CoV-2 cycle threshold (Ct) values predict future COVID-19 cases. Journal of Clinical Virology 2022. [DOI: 10.1016/j.jcv.2022.105153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 89 |
Kucharski AJ, Cohen C. Effective surveillance of variants. Science 2022;375:1349-50. [PMID: 35324314 DOI: 10.1126/science.abo4257] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 90 |
Faucher B, Assab R, Roux J, Levy-Bruhl D, Tran Kiem C, Cauchemez S, Zanetti L, Colizza V, Boëlle PY, Poletto C. Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19. Nat Commun 2022;13:1414. [PMID: 35301289 DOI: 10.1038/s41467-022-29015-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 91 |
Bolze A, Luo S, White S, Cirulli ET, Wyman D, Dei Rossi A, Machado H, Cassens T, Jacobs S, Schiabor Barrett KM, Tanudjaja F, Tsan K, Nguyen J, Ramirez JM 3rd, Sandoval E, Wang X, Wong D, Becker D, Laurent M, Lu JT, Isaksson M, Washington NL, Lee W. SARS-CoV-2 variant Delta rapidly displaced variant Alpha in the United States and led to higher viral loads. Cell Rep Med 2022;3:100564. [PMID: 35474739 DOI: 10.1016/j.xcrm.2022.100564] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 92 |
Takahashi K, Ishikane M, Ujiie M, Iwamoto N, Okumura N, Sato T, Nagashima M, Moriya A, Suzuki M, Hojo M, Kanno T, Saito S, Miyamoto S, Ainai A, Tobiume M, Arashiro T, Fujimoto T, Saito T, Yamato M, Suzuki T, Ohmagari N. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees. Emerg Infect Dis 2022;28. [PMID: 35290176 DOI: 10.3201/eid2805.220197] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 93 |
Tripp RA, Martin DE. Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication. Viruses 2022;14:612. [DOI: 10.3390/v14030612] [Reference Citation Analysis]
|
| 94 |
Koelle K, Martin MA, Antia R, Lopman B, Dean NE. The changing epidemiology of SARS-CoV-2. Science 2022;375:1116-21. [PMID: 35271324 DOI: 10.1126/science.abm4915] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 46.0] [Reference Citation Analysis]
|
| 95 |
Winnett AV, Porter MK, Romano AE, Savela ES, Akana R, Shelby N, Reyes JA, Schlenker NW, Cooper MM, Carter AM, Ji J, Barlow JT, Tognazzini C, Feaster M, Goh Y, Ismagilov RF. Morning SARS-CoV-2 testing yields better detection of infection due to higher viral loads in saliva and nasal swabs upon waking.. [DOI: 10.1101/2022.03.02.22271724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 96 |
Park J, Foox J, Hether T, Danko DC, Warren S, Kim Y, Reeves J, Butler DJ, Mozsary C, Rosiene J, Shaiber A, Afshin EE, MacKay M, Rendeiro AF, Bram Y, Chandar V, Geiger H, Craney A, Velu P, Melnick AM, Hajirasouliha I, Beheshti A, Taylor D, Saravia-Butler A, Singh U, Wurtele ES, Schisler J, Fennessey S, Corvelo A, Zody MC, Germer S, Salvatore S, Levy S, Wu S, Tatonetti NP, Shapira S, Salvatore M, Westblade LF, Cushing M, Rennert H, Kriegel AJ, Elemento O, Imielinski M, Rice CM, Borczuk AC, Meydan C, Schwartz RE, Mason CE. System-wide transcriptome damage and tissue identity loss in COVID-19 patients. Cell Rep Med 2022;3:100522. [PMID: 35233546 DOI: 10.1016/j.xcrm.2022.100522] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 97 |
Accorsi EK, Britton A, Fleming-Dutra KE, Smith ZR, Shang N, Derado G, Miller J, Schrag SJ, Verani JR. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants. JAMA 2022;327:639-51. [PMID: 35060999 DOI: 10.1001/jama.2022.0470] [Cited by in Crossref: 385] [Cited by in F6Publishing: 276] [Article Influence: 385.0] [Reference Citation Analysis]
|
| 98 |
Brümmer LE, Katzenschlager S, Mcgrath S, Schmitz S, Gaeddert M, Erdmann C, Bota M, Grilli M, Larmann J, Weigand MA, Pollock NR, Macé A, Erkosar B, Carmona S, Sacks JA, Ongarello S, Denkinger CM. Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: an updated systematic review and meta-analysis with meta regression analyzing influencing factors.. [DOI: 10.1101/2022.02.11.22270831] [Reference Citation Analysis]
|
| 99 |
Stefanelli P, Trentini F, Guzzetta G, Marziano V, Mammone A, Sane Schepisi M, Poletti P, Molina Grané C, Manica M, Del Manso M, Andrianou X, Ajelli M, Rezza G, Brusaferro S, Merler S; COVID-19 National Microbiology Surveillance Study Group. Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021. Euro Surveill 2022;27. [PMID: 35115077 DOI: 10.2807/1560-7917.ES.2022.27.5.2100429] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 100 |
Achenbach CJ, Caputo M, Hawkins C, Balmert LC, Qi C, Odorisio J, Dembele E, Jackson A, Abbas H, Frediani JK, Levy JM, Rebolledo PA, Kempker RR, Esper AM, Lam WA, Martin GS, Murphy RL. Clinical evaluation of the Diagnostic Analyzer for Selective Hybridization (DASH): a point-of-care PCR test for rapid detection of SARS-CoV-2 infection.. [DOI: 10.1101/2022.01.24.22269785] [Reference Citation Analysis]
|
| 101 |
Drain PK. Rapid Diagnostic Testing for SARS-CoV-2. N Engl J Med 2022;386:264-72. [PMID: 34995029 DOI: 10.1056/NEJMcp2117115] [Cited by in Crossref: 73] [Cited by in F6Publishing: 45] [Article Influence: 73.0] [Reference Citation Analysis]
|
| 102 |
Padmanabhan P, Dixit NM. Modelling how the altered usage of cell entry pathways by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and Cathepsin B/L inhibitors.. [DOI: 10.1101/2022.01.13.476267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 103 |
Hay JA, Kissler SM, Fauver JR, Mack C, Tai CG, Samant RM, Connolly S, Anderson DJ, Khullar G, Mackay M, Patel M, Kelly S, Manhertz A, Eiter I, Salgado D, Baker T, Howard B, Dudley JT, Mason CE, Nair M, Huang Y, Difiori J, Ho DD, Grubaugh ND, Grad YH. Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: a retrospective cohort study.. [DOI: 10.1101/2022.01.13.22269257] [Cited by in Crossref: 48] [Cited by in F6Publishing: 56] [Article Influence: 48.0] [Reference Citation Analysis]
|
| 104 |
Choi SJ, Jung J, Kim ES, Kim HB, Park JS, Park KU, Lee H, Lee E, Choe PG, Kim J, Lee EJ, Song K. Diagnostic Performance, Stability, and Usability of Self-Collected Combo Swabs and Saliva for Coronavirus Disease 2019 Diagnosis: A Case-Control Study. Infect Chemother 2022;54:517. [DOI: 10.3947/ic.2022.0081] [Reference Citation Analysis]
|
| 105 |
Kent SJ, Khoury DS, Reynaldi A, Juno JA, Wheatley AK, Stadler E, John Wherry E, Triccas J, Sasson SC, Cromer D, Davenport MP. Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast? Nat Rev Immunol 2022;22:387-97. [PMID: 35484322 DOI: 10.1038/s41577-022-00716-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 38.0] [Reference Citation Analysis]
|
| 106 |
Koutsakos M, Lee WS, Reynaldi A, Tan H, Gare G, Kinsella P, Liew KC, Williamson DA, Kent HE, Stadler E, Cromer D, Khoury DS, Wheatley AK, Juno JA, Davenport MP, Kent SJ. Dynamics of immune recall following SARS-CoV-2 vaccination or breakthrough infection.. [DOI: 10.1101/2021.12.23.21268285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 107 |
Higdon MM, Wahl B, Jones CB, Rosen JG, Truelove SA, Baidya A, Nande AA, Shamaeizadeh PA, Walter KK, Feikin DR, Patel MK, Knoll MD, Hill AL. A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease.. [DOI: 10.1101/2021.09.17.21263549] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 108 |
Riemersma KK, Haddock LA, Wilson NA, Minor N, Eickhoff J, Grogan BE, Kita-yarbro A, Halfmann PJ, Segaloff HE, Kocharian A, Florek KR, Westergaard R, Bateman A, Jeppson GE, Kawaoka Y, O’connor DH, Friedrich TC, Grande KM. Shedding of Infectious SARS-CoV-2 Despite Vaccination.. [DOI: 10.1101/2021.07.31.21261387] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 34.5] [Reference Citation Analysis]
|
| 109 |
Watson JA, Kissler S, Day NP, Grad Y, White NJ. Characterising SARS-CoV-2 viral clearance kinetics to improve the design of antiviral pharmacometric studies.. [DOI: 10.1101/2021.01.06.21249368] [Reference Citation Analysis]
|
